220 related articles for article (PubMed ID: 20597189)
1. Placebo effects in treating migraine and other headaches.
Diener HC
Curr Opin Investig Drugs; 2010 Jul; 11(7):735-9. PubMed ID: 20597189
[TBL] [Abstract][Full Text] [Related]
2. The importance of placebo in headache research.
Diener HC; Schorn CF; Bingel U; Dodick DW
Cephalalgia; 2008 Oct; 28(10):1003-11. PubMed ID: 18727647
[TBL] [Abstract][Full Text] [Related]
3. Placebo effects in oral triptan trials: the scientific and ethical rationale for continued use of placebo controls.
Loder E; Goldstein R; Biondi D
Cephalalgia; 2005 Feb; 25(2):124-31. PubMed ID: 15658949
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
[TBL] [Abstract][Full Text] [Related]
5. Migraine treatment and placebo effect.
Speciali JG; Peres M; Bigal ME
Expert Rev Neurother; 2010 Mar; 10(3):413-9. PubMed ID: 20187863
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials.
Shuhendler AJ; Lee S; Siu M; Ondovcik S; Lam K; Alabdullatif A; Zhang X; Machado M; Einarson TR
Pharmacotherapy; 2009 Jul; 29(7):784-91. PubMed ID: 19558252
[TBL] [Abstract][Full Text] [Related]
7. Eletriptan for the acute treatment of migraine in adolescents: results of a double-blind, placebo-controlled trial.
Winner P; Linder SL; Lipton RB; Almas M; Parsons B; Pitman V
Headache; 2007 Apr; 47(4):511-8. PubMed ID: 17445100
[TBL] [Abstract][Full Text] [Related]
8. Predictors of migraine headache recurrence: a pooled analysis from the eletriptan database.
Dodick DW; Lipton RB; Goadsby PJ; Tfelt-Hansen P; Ferrari MD; Diener HC; Almas M; Albert KS; Parsons B
Headache; 2008 Feb; 48(2):184-93. PubMed ID: 18234045
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
10. The placebo response in studies of acute migraine.
Fernandes R; Ferreira JJ; Sampaio C
J Pediatr; 2008 Apr; 152(4):527-33, 533.e1. PubMed ID: 18346509
[TBL] [Abstract][Full Text] [Related]
11. Acute treatment of migraine in children and adolescents.
Termine C; Ferri M; Balottin U
Funct Neurol; 2008; 23(2):63-9. PubMed ID: 18671905
[TBL] [Abstract][Full Text] [Related]
12. Ethical problems arising from the use of placebo in clinical trials with drugs for migraine. Their analysis by the moral deliberation method.
Frías J; Pascual J; Lahuerta J; Gracia D; Dal-Ré R
Neurologia; 2011 Mar; 26(2):92-9. PubMed ID: 21163201
[TBL] [Abstract][Full Text] [Related]
13. Intravenous dexamethasone vs placebo as adjunctive therapy to reduce the recurrence rate of acute migraine headaches: a multicenter, double-blinded, placebo-controlled randomized clinical trial.
Donaldson D; Sundermann R; Jackson R; Bastani A
Am J Emerg Med; 2008 Feb; 26(2):124-30. PubMed ID: 18272089
[TBL] [Abstract][Full Text] [Related]
14. Efficacy, speed of action and tolerability of almotriptan in the acute treatment of migraine: pooled individual patient data from four randomized, double-blind, placebo-controlled clinical trials.
Dahlöf CG; Pascual J; Dodick DW; Dowson AJ
Cephalalgia; 2006 Apr; 26(4):400-8. PubMed ID: 16556240
[TBL] [Abstract][Full Text] [Related]
15. Symptomatic and prophylactic treatment of migraine and tension-type headache.
Schulman EA; Silberstein SD
Neurology; 1992 Mar; 42(3 Suppl 2):16-21. PubMed ID: 1557187
[TBL] [Abstract][Full Text] [Related]
16. Placebo efficacy in childhood and adolescence migraine: an analysis of double-blind and placebo-controlled studies.
Evers S; Marziniak M; Frese A; Gralow I
Cephalalgia; 2009 Apr; 29(4):436-44. PubMed ID: 19170687
[TBL] [Abstract][Full Text] [Related]
17. [Drug treatment of migraine in children: state of the art].
Cuvellier JC; Joriot S; Auvin S; Vallée L
Arch Pediatr; 2004 May; 11(5):449-55. PubMed ID: 15135430
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.
Dodick DW; Mauskop A; Elkind AH; DeGryse R; Brin MF; Silberstein SD;
Headache; 2005 Apr; 45(4):315-24. PubMed ID: 15836567
[TBL] [Abstract][Full Text] [Related]
19. Botulinum toxin type A (Botox) in the treatment of migraine and other headaches.
Troost BT
Expert Rev Neurother; 2004 Jan; 4(1):27-31. PubMed ID: 15853612
[TBL] [Abstract][Full Text] [Related]
20. Phenotype-driven preventive strategies for migraine and other headaches.
Wheeler SD
Neurologist; 2009 Mar; 15(2):59-70. PubMed ID: 19276783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
